Pharmaceuticals company Organon wants owners Merck to sell the company rather than move its R&D unit to the US and shut down its production lines, according to anonymous sources in Friday’s Financieele Dagblad.

Organon is a niche player in women’s health, producing contraceptive pills, fertility treatments and hormones. It was taken over by pharmaceuticals giant Merck in 2009.
According to the sources, there are a few companies in Europe active in women’s health that would be a good match for Organon.
The company has declined to comment, says the Financieele Dagblad.